Yes, there are warning signs of lacosamide-induced arrhythmia. Lacosamide is a medication used to treat partial-onset seizures and is available under the brand name Vimpat. According to the drug's prescribing information, ventricular tachycardia, a type of arrhythmia, has been reported in patients receiving lacosamide [1].

Healthcare professionals should be aware of the potential risk of arrhythmia in patients taking lacosamide. The prescribing information states that ventricular tachycardia has been reported in patients receiving lacosamide, and in some cases, it has resulted in asystole, syncope, and death [1].

Patients taking lacosamide should be monitored for symptoms of arrhythmia, including palpitations, rapid heartbeat, and shortness of breath. If these symptoms occur, patients should seek medical attention immediately [1].

It is important to note that while arrhythmia is a potential side effect of lacosamide, it is a rare occurrence. According to DrugPatentWatch.com, the FDA has received reports of serious adverse events, including arrhythmia, in patients taking lacosamide, but the incidence is low [2].

In summary, while arrhythmia is a potential side effect of lacosamide, it is a rare occurrence. Healthcare professionals should monitor patients taking lacosamide for symptoms of arrhythmia, and patients should seek medical attention immediately if they experience symptoms.

Sources:

1. Vimpat (lacosamide) tablets for oral use. Prescribing information. UCB, Inc. December 2021. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202353s033lbl.pdf>.
2. Lacosamide. DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/lacosamide>.